Generation of long-lived plasma cells to serogroup B Neisseria meningitidis after murine immunisation with an outer membrane protein vaccine

Vaccine

Volumn 25, Issue 27, 2007, Pages 5046-5052

  Cruz, Simone C ^a   Cruz, Aline C ^a   Oliveira, Juliana M ^a   Soares, Amanda M ^b   Gioia, Carolina A C ^c   Milagres, Lucimar G ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Universidade Castelo Branco   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

Long lived plasma cells; OMP vaccine; Serogroup B Neisseria meningitidis

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VA MENGOC BC;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; EPIDEMIC MENINGITIS; FEMALE; IMMUNIZATION; MEMORY CELL; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SPLEEN; VACCINATION;

ANIMALS; ANTIBODY FORMATION; BACTERIAL OUTER MEMBRANE PROTEINS; BLOOD BACTERICIDAL ACTIVITY; BONE MARROW CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; MENINGOCOCCAL VACCINES; MICE; NEISSERIA MENINGITIDIS; PLASMA CELLS; SPLEEN;

EID: 34249985005     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.051     Document Type: Article

References (30)

1. Lemos A.P., Brandao A.P., Gorla M.C., Paiva M.V., Simonsen V., and Melles C.E. Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001. J Med Microbiol 55 (2006) 751-757
2. Cartwright K., et al. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European Advisory Board Meeting. Vienna, Austria, October 6-8, 2000. Vaccine 19 31 (2001) 4347-4356
3. Giuliani M.M., Adu-Bobie J., Commnducci M., Aricó B., Savino S., Santini L., et al. A universal vaccine for serogroup B meningococcus. PNAS 103 (2006) 10834-10839
4. Oster P., Lennon D., O'Hallahan J., Mulholland K., Reid S., and Martin D. MeNZB™: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 23 (2005) 2191-2196
5. Rosenqvist E., Høiby E.A., Wedege E., Bryn K., Kolberg J., Klem A., et al. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun 63 12 (1995) 4642-4652
6. Bjune G., Høiby E.A., Grønnesby J.K., Arnesen O., Fredriksen J.H., Halstensen A., et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338 (1991) 1093-1096
7. Feiring B., Fuglesang J., Oster P., Næss L.M., Helland O.S., Tilman S., et al. Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine. Clin Vaccine Immunol 13 (2006) 790-796
8. Gioia C.A.C., Sousa A.B., Cruz S.C., Junior F.C.S., Andrade A.F.B., Sassi R.M., et al. Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules. FEMS Immunol Med Microbiol 40 (2005) 35-42
9. Kelly D.F., Pollard A.J., and Moxon E.R. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 294 (2005) 3019-3023
10. Nanan R., Heinrich D., Frosch M., and Kreth H.W. Acute and long-term effects of booster immunization on frequencies of antigen-specific memory-B lymphocytes. Vaccine 20 (2002) 498-504
11. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
12. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G.C., Dörner T., et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6 (2006) 741-750
13. Slifka M.K., Matloubian M., and Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 69 (1995) 1895-1902
14. Slifka M.K., and Ahmed R. B cell responses and immune memory. Dev Biol Stand Basel 95 (1998) 105-115
15. ® against disease caused by serogroup B Neisseria meningitidis. In: 7th International Pathogenic Neisseria Conference 1990. pp. 129-34.
16. Tsai C.M., and Frasch C.E. Chemical analysis of major outer membrane proteins of Neisseria meningitidis: comparison of serotypes 2 and 11. J Bacteriol 141 (1980) 169-176
17. Milagres L.M., Ramos S.R., Sacchi C.T., Melles C.E.A., Vieira V.S.D., Sato H., et al. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect Immun 62 (1994) 4419-4424
18. Plikaytis B.D., Holder P.F., and Carlone G.M. Program ELISA for windows user's manual, version 2.01 (2002), Centers for Disease Control and Prevention, Atlanta, GA, USA
19. Holst J., Feiring B., Næss L.M., Norheim G., Kristiansen P., Høiby E.A., et al. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine 23 (2005) 2202-2205
20. Rouaud P., Perrocheau A., Taha M.K., Sesboué C., Forgues A., Parent du Châtelet I., et al. Prolonged outbreak of B meningococcal disease in the Seine-Maritime Department, France, January 2003 to June 2005. Euro Surveill 1 (2006) 178-181
21. Moraes J.C., Perkins B.A., Camargo M.C.C., Hidalgo N.T., Barbosa H.A., Sacchi C.T., et al. Protective efficacy of a serogroup B meningococcal vaccine in São Paulo. Lancet 340 (1992) 1074-1078
22. Borrow R., Balmer P., and Miller E. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 23 (2005) 2222-2227
23. Manz R.A., Hauser A.E., Hiepe F., and Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 23 (2005) 367-386
24. Luijkx TA, van Gaans-van den Brink JA, van den Dobbelsteen GP, van Els CA. B cell ELISPOT to study long-term B cell immunity to PorA in mice. In: 14th International Pathogenic Neisseria Conference 2004. p. 172.
25. Gourley T.S., Wherry E.J., Masopust D., and Ahmed R. Generation and maintenance of immunological memory. Semin Immunol 16 5 (2004) 323-333
26. Wedege E., Høiby E.A., Rosenqvist E., and Bjune G. Immune response against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 66 (1998) 3223-3231
27. Milagres L.M., Gorla M.C.A., Rebelo M.C., and Barroso D.E. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine. FEMS Immunol Med Microbiol 28 (2000) 319-327
28. Vermont C.L., van Dijken H.H., van Limpt C.J., de Groot R., van Alphen L., and van Den Dobbelsteen G.P. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun 70 (2002) 584-590
29. Tarlinton D. B-cell memory: are subsets necessary?. Nat Rev Immunol 6 (2006) 785-790
30. Kelly D.F., Snape M., Clutterbuck E.C., Green S., Snowden C., Diggle L., et al. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigens specific memory B cells. Blood 108 8 (2006) 2642-2647